BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29268054)

  • 1. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic Fibrosis-Related Diabetes in Children: An Update.
    Kim RJ
    Pediatr Ann; 2016 Sep; 45(9):e321-6. PubMed ID: 27622916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.
    Rafii M; Chapman K; Stewart C; Kelly E; Hanna A; Wilson DC; Tullis E; Pencharz PB
    Am J Clin Nutr; 2005 Feb; 81(2):421-6. PubMed ID: 15699230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes in cystic fibrosis.
    Bridges N
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():16-8. PubMed ID: 23522600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of diabetes in cystic fibrosis patients.
    Hardin DS
    Expert Opin Pharmacother; 2010 Apr; 11(5):771-8. PubMed ID: 20166842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.
    Christian F; Thierman A; Shirley E; Allen K; Cross C; Jones K
    J Investig Med High Impact Case Rep; 2019; 7():2324709619842898. PubMed ID: 31010313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
    Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
    BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing cystic fibrosis-related diabetes: current methods and challenges.
    Prentice B; Hameed S; Verge CF; Ooi CY; Jaffe A; Widger J
    Expert Rev Respir Med; 2016 Jul; 10(7):799-811. PubMed ID: 27268400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance of cystic fibrosis-related diabetes.
    Brennan AL; Geddes DM; Gyi KM; Baker EH
    J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cystic fibrosis-related diabetes: a systematic review.
    Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
    Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the detection and management of cystic fibrosis related diabetes.
    Hameed S; Jaffé A; Verge CF
    Curr Opin Pediatr; 2015 Aug; 27(4):525-33. PubMed ID: 26087430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
    Moran A; Pekow P; Grover P; Zorn M; Slovis B; Pilewski J; Tullis E; Liou TG; Allen H;
    Diabetes Care; 2009 Oct; 32(10):1783-8. PubMed ID: 19592632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cystic fibrosis-related diabetes on health-related quality of life.
    Kwong E; Desai S; Chong L; Lee K; Zheng J; Wilcox PG; Quon BS
    J Cyst Fibros; 2019 Sep; 18(5):734-736. PubMed ID: 30935840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.